ORYZF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Oryzon Genomics SA (ORYZF) Ownership - Who owns Oryzon Genomics SA?

Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Sant Ferran 74

Phone

+34 935151313

Employees

Web

http://www.oryzon.com

Details

Group

Domestic Stock Funds

Fundamentals

ORYZF

Capitalization

200M

P/E Ratio

N/A

Risk (Beta)

-0.39

Dividend Yield

N/A

Total Cash

8.44M

Total Cash/Share

0.13

Total Debt

13.4M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

96.9M

P/B Ratio

1.83

Cash Flow

N/A

Earnings

-0.07

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

3.2M

Current Ratio

0.95

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

834K

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-3.71

Shares Held By Institutions

627K

Shares Outstanding - Current

64.7M

Total Liabilities

25.8M

Total Volume MTD

N/A

Value

Gain YTD

91.358

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology